Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Los Angeles, California 90025


Purpose:

The CTSI-PLACE Study is a study for men and women with HIV/hepatitis C co-infection or HIV only. The study looks at the impact of having hepatitis C virus in addition to HIV on risk for cardiovascular disease. Participants will undergo non-invasive assessment of cardiovascular disease risk through measurements of endothelial function and blood biomarkers at baseline and 1 year (or 4 weeks and 24 weeks after end of HCV treatment for those that undergo HCV treatment during study follow-up).


Criteria:

Inclusion Criteria 1. Men and women ≥ 18 years 2. Hepatitis C negative or chronic hepatitis C infection 3. Chronic HIV infection 4. CD4+ T-cell count > 200 cells/mm3 5. Plasma HIV-1 RNA < 50 copies/mL 6. On continuous and stable ART for at least 12 weeks 7. Ability and willingness to provide written informed consent. Exclusion Criteria 1. Known cardiovascular disease 2. Diabetes requiring insulin therapy or hemoglobin A1c > 8% 3. Inability to conform to requirements for PAT testing 4. Decompensated liver disease 5. Other known causes of significant liver disease 6. Serious illness including acute liver-related disease and malignancy requiring systemic treatment or hospitalization within 12 weeks prior to study entry 7. Presence of active or acute AIDS-defining opportunistic infections (OIs) within 12 weeks prior to study entry 8. History of major organ transplantation with an existing functional graft and on immunosuppressive therapy 9. History of known vascular or autoimmune disease 10. Pregnancy 11. HCV treatment (any approved or investigational agents) within 24 weeks prior to study entry 12. Use of immune-based therapies or systemic corticosteroids within 12 weeks prior to study entry 13. Advanced renal insufficiency as defined by glomerular filtration rate (GFR) < 30 mL/min/1.73 m2 or treatment by dialysis


NCT ID:

NCT02597790


Primary Contact:

Principal Investigator
Kara W. Chew, M.D., M.S.
University of California, Los Angeles


Backup Contact:

N/A


Location Contact:

Los Angeles, California 90025
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.